Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1,022 hedge funds and large institutions have $45.8B invested in Allergan plc in 2018 Q1 according to their latest regulatory filings, with 124 funds opening new positions, 433 increasing their positions, 351 reducing their positions, and 137 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 433 | Existing positions reduced: 351
13% more funds holding in top 10
Funds holding in top 10: 40 → 45 (+5)
3% more capital invested
Capital invested by funds: $44.5B → $45.8B (+$1.35B)
9% less first-time investments, than exits
New positions opened: 124 | Existing positions closed: 137
2% less funds holding
Funds holding: 1,048 → 1,022 (-26)
37% less call options, than puts
Call options by funds: $992M | Put options by funds: $1.58B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCIM
TIAA CREF Investment Management
New York
|
+$312M |
| 2 |
ClearBridge Investments
New York
|
+$294M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$200M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$193M |
| 5 |
Edgewood Management
Greenwich,
Connecticut
|
+$183M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$344M |
| 2 |
State Street
Boston,
Massachusetts
|
-$327M |
| 3 |
JP Morgan Chase
New York
|
-$208M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$199M |
| 5 |
D.E. Shaw & Co
New York
|
-$163M |
AGN Hedge Fund Activity: Q1 2018 in Review
1,022 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q1 2018, worth a combined $45.8B — up 3% from $44.5B a quarter earlier.
Sellers outnumbered buyers: 137 funds closed out of AGN and 124 opened new positions — a net loss of 13 holders — while 351 trimmed existing stakes and 433 added.
The largest buyer was TIAA CREF Investment Management, adding an estimated $312M. The largest seller was Fidelity Investments, cutting an estimated $344M.
- 1,022 institutional investors held Allergan plc (AGN) as of Q1 2018, down from 1,048 in Q4 2017.
- Funds reported $45.8B of Allergan plc stock for Q1 2018, up 3% quarter-over-quarter.
- 124 funds opened new Allergan plc positions in Q1 2018 and 137 closed out, a net change of -13 holders.
- The largest Allergan plc buyer in Q1 2018 was TIAA CREF Investment Management, an estimated $312M added.
- The largest Allergan plc seller in Q1 2018 was Fidelity Investments, an estimated $344M sold.
Based on aggregated 13F filings for Q1 2018.